Sleep Improvement Interventions for Inpatients with Neurological Conditions
(I_SLEEP Trial)
Trial Summary
What is the purpose of this trial?
We aim to test multiple interventions to improve sleep for Neurology inpatients, including 1) a sleep-friendly order set, and 2) a sleep menu. We will collect patient sleep data, including duration and quality, via actigraphy devices (FitBits). We will also conduct qualitative patient surveys to understand the impact of these interventions.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial team.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial team or your doctor.
What data supports the idea that Sleep Improvement Interventions for Inpatients with Neurological Conditions is an effective treatment?
The available research shows that Sleep Improvement Interventions, like the 'sleep menu', are effective in improving patients' sleep in hospitals. For example, in one study, the percentage of patients who reported getting five or more hours of uninterrupted sleep increased from 31% to 80% after the introduction of a sleep menu. This improvement was maintained over three months and also led to better patient satisfaction scores. Another study found that a program called SIESTA, which helps reduce nighttime disruptions, increased the use of sleep-friendly practices in hospitals. These interventions not only help patients sleep better but also improve their overall hospital experience.12345
What data supports the effectiveness of the treatment Sleep Improvement Interventions for Inpatients with Neurological Conditions?
Research shows that similar sleep-friendly interventions, like the 'sleep menu' in a hospital setting, significantly improved patients' sleep quality, with the percentage of patients reporting five or more hours of uninterrupted sleep rising from 31% to 80%. This suggests that structured sleep interventions can enhance sleep quality in hospital environments.12345
What safety data exists for sleep improvement interventions in hospitals?
The research does not directly provide specific safety data for sleep improvement interventions like the Sleep Menu or Sleep-Friendly Interventions. However, studies such as SIESTA and I-SLEEP focus on improving patient sleep through educational and environmental changes, which are generally non-invasive and suggest a low risk of adverse effects. The interventions aim to reduce nighttime disruptions and improve sleep quality, which can enhance patient recovery and satisfaction without introducing significant safety concerns.23467
Is the Sleep Improvement Intervention safe for inpatients with neurological conditions?
Is the treatment in the trial 'Sleep Improvement Interventions for Inpatients with Neurological Conditions' a promising treatment?
How does the SIESTA treatment for improving sleep in neurological inpatients differ from other treatments?
Research Team
Laura Stein
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for adults over 18 who have been admitted to the general neurology ward at the Hospital of the University of Pennsylvania and are stable enough not to need overnight vital signs or neurological checks. They must be symptomatically stable for more than 24 hours and able to give verbal consent.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive sleep interventions including a sleep-friendly order set and a sleep menu, with sleep data collected via actigraphy devices (FitBits)
Follow-up
Participants are monitored for sleep quality and duration using surveys and actigraphy data
Treatment Details
Interventions
- Patient sleep menu
- Sleep-friendly order set
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor